Treatments for Stimulant Use Disorder: Evaluation of the Evidence

Video Transcription

Video Summary

The video content was a presentation by Dr. Steve Shoptaw, a professor at UCLA Department of Family Medicine, discussing the treatment of stimulant use disorder. Dr. Shoptaw highlighted the lack of FDA-approved medications for stimulant use disorder, but presented evidence for the efficacy of certain medications such as mirtazapine, mixed amphetamine salts, and the combination of bupropion and naltrexone. He emphasized the importance of contingency management as a highly effective behavioral therapy and discussed the role of cognitive behavioral therapy and motivational interviewing. Dr. Shoptaw also addressed the challenges of translating evidence-based treatments into clinical practice, including the need for energetic champions, interdisciplinary collaboration, and infrastructure support. The presentation concluded with a discussion of the importance of addressing the biological, behavioral, and cultural aspects of stimulant use disorder in integrated treatment approaches.

Asset Subtitle

View the recorded presentation to attest that you have viewed the presentation in its entirety.

Keywords

stimulant use disorder

treatment

Dr. Steve Shoptaw

mirtazapine

mixed amphetamine salts

bupropion and naltrexone

contingency management

cognitive behavioral therapy

integrated treatment approaches